353 related articles for article (PubMed ID: 32478397)
1. The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases.
Dou C; Zhang H; Ke G; Zhang L; Lian Z; Chen X; Zhao X; Chen Y; Li R; Ma J; Li Z; Lin T; Wang W; Ye ZM; Liang X; Shi W; Zhang B; Liu S
Clin Sci (Lond); 2020 Jun; 134(12):1305-1318. PubMed ID: 32478397
[TBL] [Abstract][Full Text] [Related]
2. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
3. Inducible ATF3-NFAT axis aggravates podocyte injury.
Zhang H; Liang S; Du Y; Li R; He C; Wang W; Liu S; Ye Z; Liang X; Shi W; Zhang B
J Mol Med (Berl); 2018 Jan; 96(1):53-64. PubMed ID: 29038896
[TBL] [Abstract][Full Text] [Related]
4. Krüppel-Like Factor 15 Mediates Glucocorticoid-Induced Restoration of Podocyte Differentiation Markers.
Mallipattu SK; Guo Y; Revelo MP; Roa-Peña L; Miller T; Ling J; Shankland SJ; Bialkowska AB; Ly V; Estrada C; Jain MK; Lu Y; Ma'ayan A; Mehrotra A; Yacoub R; Nord EP; Woroniecki RP; Yang VW; He JC
J Am Soc Nephrol; 2017 Jan; 28(1):166-184. PubMed ID: 27288011
[TBL] [Abstract][Full Text] [Related]
5. Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation.
Mallipattu SK; Liu R; Zheng F; Narla G; Ma'ayan A; Dikman S; Jain MK; Saleem M; D'Agati V; Klotman P; Chuang PY; He JC
J Biol Chem; 2012 Jun; 287(23):19122-35. PubMed ID: 22493483
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
[TBL] [Abstract][Full Text] [Related]
7. RANK Deficiency Ameliorates Podocyte Injury by Suppressing Calcium/Calcineurin/ NFATc1 Signaling.
Liang S; Zhang H; Du Y; Dou C; Liu S; Zhang L; Chen Y; Li R; Ma J; Li Z; Lin T; Zhao X; Zhang Q; Wang W; Ye Z; Liang X; Shi W; Zhang B
Kidney Blood Press Res; 2018; 43(4):1149-1159. PubMed ID: 30036881
[TBL] [Abstract][Full Text] [Related]
8. NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression.
Li R; Zhang L; Shi W; Zhang B; Liang X; Liu S; Wang W
Exp Cell Res; 2013 Apr; 319(7):992-1000. PubMed ID: 23340267
[TBL] [Abstract][Full Text] [Related]
9. Loss of KLF15 accelerates chronic podocyte injury.
Han SS; Yu MY; Yoo KD; Lee JP; Kim DK; Kim YS; Yang SH
Int J Mol Med; 2018 Sep; 42(3):1593-1602. PubMed ID: 29901095
[TBL] [Abstract][Full Text] [Related]
10. The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.
Zhang B; Shi W; Ma J; Sloan A; Faul C; Wei C; Reiser J; Yang Y; Liu S; Wang W
J Mol Med (Berl); 2012 Dec; 90(12):1407-20. PubMed ID: 23015147
[TBL] [Abstract][Full Text] [Related]
11. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.
Wu J; Zheng C; Fan Y; Zeng C; Chen Z; Qin W; Zhang C; Zhang W; Wang X; Zhu X; Zhang M; Zen K; Liu Z
J Am Soc Nephrol; 2014 Jan; 25(1):92-104. PubMed ID: 24029422
[TBL] [Abstract][Full Text] [Related]
13. MiR-30 family prevents uPAR-ITGB3 signaling activation through calcineurin-NFATC pathway to protect podocytes.
Lang Y; Zhao Y; Zheng C; Lu Y; Wu J; Zhu X; Zhang M; Yang F; Xu X; Shi S; Liu Z
Cell Death Dis; 2019 May; 10(6):401. PubMed ID: 31127093
[TBL] [Abstract][Full Text] [Related]
14. Krüppel-like factor 15 is a key suppressor of podocyte fibrosis under rotational force-driven pressure.
Yu MY; Kim JE; Lee S; Choi JW; Kim YC; Han SS; Lee H; Cha RH; Lee JP; Lee JW; Kim DK; Kim YS; Yang SH
Exp Cell Res; 2020 Jan; 386(1):111706. PubMed ID: 31697927
[TBL] [Abstract][Full Text] [Related]
15. C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.
Mo H; Wu Q; Miao J; Luo C; Hong X; Wang Y; Tang L; Hou FF; Liu Y; Zhou L
Antioxid Redox Signal; 2017 Aug; 27(6):345-362. PubMed ID: 27960539
[TBL] [Abstract][Full Text] [Related]
16. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
17. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury.
Liu H; Gao X; Xu H; Feng C; Kuang X; Li Z; Zha X
Nephrology (Carlton); 2012 Nov; 17(8):669-75. PubMed ID: 22804863
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
[TBL] [Abstract][Full Text] [Related]
19. GAP-43 ameliorates Podocyte injury by decreasing nuclear NFATc1 expression.
Lian Z; Ke G; Zhang H; Dou C; Chen X; Li B; Zhang F; Wen S; Wu Q; Xia Y; Jiang N; Li Z; Li S; Zhao X; Ma J; Lin T; Wen F; Xu L; Li Z; Liang H; Dong W; Chen Y; Li R; Ye Z; Wang W; Liang X; Shi W; Zhang L; Liu S
Biochem Biophys Rep; 2021 Dec; 28():101145. PubMed ID: 34746448
[TBL] [Abstract][Full Text] [Related]
20. SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension.
Li N; Zhang J; Yan X; Zhang C; Liu H; Shan X; Li J; Yang Y; Huang C; Zhang P; Zhang Y; Bu P
Oncotarget; 2017 Jun; 8(24):39592-39604. PubMed ID: 28465484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
